Jeffrey Alan Barnes, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jeffrey Barnes's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jeffrey Barnes has written about over time.
Antibodies, Monoclonal, Murine-DerivedLeukemia-Lymphoma, Adult T-CellLymphoma, Large B-Cell, DiffuseLymph NodesLymphoma, B-CellAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinCentral Nervous System NeoplasmsNeutropeniaHodgkin DiseaseAntigens, CD19Immunotherapy, AdoptiveDacarbazineVinblastineNeurotoxicity SyndromesLeukemia, Lymphocytic, Chronic, B-CellCysts
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Antibodies, Monoclonal, Murine-Derived | 4 | 2010 | 2013 | September 2012 |
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2009 | 2016 | March 2013 |
| Lymphoma, Large B-Cell, Diffuse | 4 | 2010 | 2018 | December 2013 |
| Lymph Nodes | 2 | 2013 | 2014 | January 2014 |
| Lymphoma, B-Cell | 4 | 2013 | 2019 | April 2015 |
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2009 | 2023 | January 2016 |
| Doxorubicin | 5 | 2010 | 2023 | February 2016 |
| Central Nervous System Neoplasms | 2 | 2010 | 2023 | April 2017 |
| Neutropenia | 2 | 2012 | 2023 | January 2018 |
| Hodgkin Disease | 3 | 2015 | 2023 | May 2019 |
| Antigens, CD19 | 1 | 2019 | 2019 | September 2019 |
| Immunotherapy, Adoptive | 3 | 2019 | 2023 | December 2020 |
| Dacarbazine | 2 | 2019 | 2023 | May 2021 |
| Vinblastine | 2 | 2019 | 2023 | May 2021 |
| Neurotoxicity Syndromes | 2 | 2019 | 2023 | July 2021 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 2022 | January 2022 |
| Cysts | 1 | 2022 | 2022 | August 2022 |